BOL-303259-X

DRUG4 trials

Sponsors

Bausch & Lomb Incorporated

Conditions

Intraocular PressureOcular HypertensionOpen Angle GlaucomaOpen-Angle Glaucoma

Phase 2

Study Comparing the Safety and Efficacy of BOL-303259-X to Latanoprost in Subjects With Glaucoma or Ocular Hypertension

CompletedNCT01223378

Bausch & Lomb IncorporatedIntraocular Pressure

Start: 2010-12-13End: 2012-06-22Updated: 2018-07-24

BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension

CompletedNCT01707381

Bausch & Lomb IncorporatedOcular Hypertension, Open Angle Glaucoma

Start: 2012-11-30End: 2014-02-28Updated: 2018-09-04

Phase 3

Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular Hypertension

CompletedNCT01749930

Bausch & Lomb IncorporatedOcular Hypertension, Open-Angle Glaucoma

Start: 2013-01-31End: 2015-05-31Updated: 2018-11-21

Comparing Safety and Efficacy of BOL-303259-X With Timolol Maleate in Subjects With Open-Angle Glaucoma or Ocular Hypertension

CompletedNCT01749904

Bausch & Lomb IncorporatedOcular Hypertension, Open-Angle Glaucoma

Start: 2013-01-31End: 2015-09-30Updated: 2018-11-07

Related Papers

Long-term Safety and Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: The JUPITER Study.

2016-07-2548 citations

A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study

British Journal of Ophthalmology2014-12-08168 citations